“The Power of Two: Effective Management of Severe Refractory Psoriasis Through Combined TYK2 and IL-23 Inhibition”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 5, Sept. 2025, pp. 2669-73, https://doi.org/10.25251/kj8rwg98.